Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - DEPRECIATION & AMORTIZATION
Depreciation & Amortization FDMT - 4D Molecular Therapeutics, Inc.
5.75 M
LAST VALUE
37.97%
2 YEAR CAGR
52.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR